OPTi, Inc.
OPTi, Inc. (OTC: OPTI)
MURRAY FRANK LLP is investigating possible breaches of fiduciary duties by members of the board of directors of OPTi, Inc. (OTC: OPTI) (“OPTi” or the “Company”) in relation to the board’s approval of the voluntary winding up and dissolution of the Company pursuant to a Plan of Liquidation (the “Proposed Liquidation”).
The investigation focuses on whether OPTi’s board of directors breached their fiduciary duties and violated securities laws in connection with their unanimous vote to liquidate the Company’s assets.
On January 12, 2012, OPTi filed a Schedule 14A preliminary proxy statement (the “Proxy”) with the Securities and Exchange Commission announcing that it had unanimously approved the Proposed Liquidation. The investigation concerns whether the Proposed Liquidation is in the best interests of the Company’s stockholders, including whether the Proposed Liquidation - which does not take into account the value of patent infringement claims that the Company has against other entities that have infringed on its patents – adequately compensates the OPTi’s stockholders and reflects the Company’s true value. The investigation also concerns whether the Proxy fails to provide material information, and/or provides materially misleading information, such that OPTi’s stockholders are unable to make an informed decision as to whether to consent to the Proposed Liquidation.
If you are a current investor in OPTi, and you wish to discuss this investigation or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Bridget V. Hamill at (800) 497-8076 or (212) 682-1818, or by email at [email protected].
Contact:
MURRAY FRANK LLP
Bridget V. Hamill
(800) 497-8076
(212) 682-1818
[email protected]
www.murrayfrank.com
MURRAY FRANK LLP is investigating possible breaches of fiduciary duties by members of the board of directors of OPTi, Inc. (OTC: OPTI) (“OPTi” or the “Company”) in relation to the board’s approval of the voluntary winding up and dissolution of the Company pursuant to a Plan of Liquidation (the “Proposed Liquidation”).
The investigation focuses on whether OPTi’s board of directors breached their fiduciary duties and violated securities laws in connection with their unanimous vote to liquidate the Company’s assets.
On January 12, 2012, OPTi filed a Schedule 14A preliminary proxy statement (the “Proxy”) with the Securities and Exchange Commission announcing that it had unanimously approved the Proposed Liquidation. The investigation concerns whether the Proposed Liquidation is in the best interests of the Company’s stockholders, including whether the Proposed Liquidation - which does not take into account the value of patent infringement claims that the Company has against other entities that have infringed on its patents – adequately compensates the OPTi’s stockholders and reflects the Company’s true value. The investigation also concerns whether the Proxy fails to provide material information, and/or provides materially misleading information, such that OPTi’s stockholders are unable to make an informed decision as to whether to consent to the Proposed Liquidation.
If you are a current investor in OPTi, and you wish to discuss this investigation or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Bridget V. Hamill at (800) 497-8076 or (212) 682-1818, or by email at [email protected].
Contact:
MURRAY FRANK LLP
Bridget V. Hamill
(800) 497-8076
(212) 682-1818
[email protected]
www.murrayfrank.com